Work

Disruptive Psychopharmacology

Year: 2019

Type: article

Abstract: This Viewpoint discusses the potential therapeutic utility of methylenedioxy-methamphetamine and psilocybin and outlines mental health care infrastructures that would need to be put in place should these drugs be approved for treatment.

Source: JAMA Psychiatry

DOI: 10.1001/jamapsychiatry.2019.1145

Authors: Boris D. Heifets, Robert C. Malenka

Institutions: Stanford Medicine, Stanford University

Language: English

Topic: Psychedelics and Drug Studies

Subfield: Clinical Psychology

Field: Psychology

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institute of Mental Health

Award: G681024484

OpenAlex ID: W4231328231

FWCI: 4.598

Cites: 7

Cited by: 30

Related to: 10